Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Development of quality indicators for the management of Staphylococcus aureus bacteraemia.

Ten Oever J, Jansen JL, van der Vaart TW, Schouten JA, Hulscher MEJL, Verbon A.

J Antimicrob Chemother. 2019 Aug 8. pii: dkz342. doi: 10.1093/jac/dkz342. [Epub ahead of print]

PMID:
31393551
2.

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex.

Overwater IE, Rietman AB, Mous SE, Bindels-de Heus K, Rizopoulos D, Ten Hoopen LW, van der Vaart T, Jansen FE, Elgersma Y, Moll HA, de Wit MY; ENCORE Expertise Centre for Neurodevelopmental Disorders.

Neurology. 2019 Jul 9;93(2):e200-e209. doi: 10.1212/WNL.0000000000007749. Epub 2019 Jun 19.

PMID:
31217257
3.

Activation of coagulation and endothelium with concurrent impairment of anticoagulant mechanisms in patients with typhoid fever.

de Jong HK, Parry CM, van der Vaart TW, Kager LM, van den Ende SJ, Maude RR, Wijedoru L, Ghose A, Hassan MU, Hossain MA, Dondorp AM, Baker S, Faiz MA, Meijers JCM, Wiersinga WJ.

J Infect. 2018 Jul;77(1):60-67. doi: 10.1016/j.jinf.2018.03.008. Epub 2018 May 7.

4.

Hurry up, it's quiet in the emergency department.

Ter Avest E, Onnes BT, van der Vaart T, Land MJ.

Neth J Med. 2018 Jan;76(1):32-35.

5.

Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1.

Rietman AB, van der Vaart T, Plasschaert E, Nicholson BA, Oostenbrink R, Krab LC, Descheemaeker MJ, Wit MY, Moll HA, Legius E, Nijs PFA.

Am J Med Genet B Neuropsychiatr Genet. 2018 Apr;177(3):319-328. doi: 10.1002/ajmg.b.32612. Epub 2017 Dec 15.

PMID:
29243874
6.

Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.

Walsh KS, Janusz J, Wolters PL, Moll HA, van der Vaart T, Rietman AB.

Neurology. 2016 May 10;86(19):1849-50. doi: 10.1212/WNL.0000000000002687. No abstract available.

PMID:
27164720
7.

Differential Toll-Like Receptor-Signalling of Burkholderia pseudomallei Lipopolysaccharide in Murine and Human Models.

Weehuizen TA, Prior JL, van der Vaart TW, Ngugi SA, Nepogodiev SA, Field RA, Kager LM, van 't Veer C, de Vos AF, Wiersinga WJ.

PLoS One. 2015 Dec 21;10(12):e0145397. doi: 10.1371/journal.pone.0145397. eCollection 2015.

8.

Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.

van der Vaart T, Rietman AB, Plasschaert E, Legius E, Elgersma Y, Moll HA; NF1-SIMCODA Study Group.

Neurology. 2016 Jan 12;86(2):154-60. doi: 10.1212/WNL.0000000000002118. Epub 2015 Oct 30.

9.

Treatment of Cognitive Deficits in Genetic Disorders: A Systematic Review of Clinical Trials of Diet and Drug Treatments.

van der Vaart T, Overwater IE, Oostenbrink R, Moll HA, Elgersma Y.

JAMA Neurol. 2015 Sep;72(9):1052-60. doi: 10.1001/jamaneurol.2015.0443. Review.

PMID:
26168015
10.

HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.

Omrani A, van der Vaart T, Mientjes E, van Woerden GM, Hojjati MR, Li KW, Gutmann DH, Levelt CN, Smit AB, Silva AJ, Kushner SA, Elgersma Y.

Mol Psychiatry. 2015 Nov;20(11):1311-21. doi: 10.1038/mp.2015.48. Epub 2015 Apr 28.

11.

Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues.

Rauen KA, Huson SM, Burkitt-Wright E, Evans DG, Farschtschi S, Ferner RE, Gutmann DH, Hanemann CO, Kerr B, Legius E, Parada LF, Patton M, Peltonen J, Ratner N, Riccardi VM, van der Vaart T, Vikkula M, Viskochil DH, Zenker M, Upadhyaya M.

Am J Med Genet A. 2015 Jan;167A(1):1-10. doi: 10.1002/ajmg.a.36793. Epub 2014 Nov 12.

12.

Update from the 2013 International Neurofibromatosis Conference.

Plotkin SR, Albers AC, Babovic-Vuksanovic D, Blakeley JO, Breakefield XO, Dunn CM, Evans DG, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Kalamarides M, McClatchey AI, Messiaen L, Morrison H, Parkinson DB, Stemmer-Rachamimov AO, Van Raamsdonk CD, Riccardi VM, Rosser T, Schindeler A, Smith MJ, Stevenson DA, Ullrich NJ, van der Vaart T, Weiss B, Widemann BC, Zhu Y, Bakker AC, Lloyd AC.

Am J Med Genet A. 2014 Dec;164A(12):2969-78. doi: 10.1002/ajmg.a.36754. Epub 2014 Sep 24. No abstract available.

13.

Severe murine typhus with pulmonary system involvement.

van der Vaart TW, van Thiel PP, Juffermans NP, van Vugt M, Geerlings SE, Grobusch MP, Goorhuis A.

Emerg Infect Dis. 2014 Aug;20(8):1375-7. doi: 10.3201/eid2008.131421. Review.

14.

Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.

van der Vaart T, Plasschaert E, Rietman AB, Renard M, Oostenbrink R, Vogels A, de Wit MC, Descheemaeker MJ, Vergouwe Y, Catsman-Berrevoets CE, Legius E, Elgersma Y, Moll HA.

Lancet Neurol. 2013 Nov;12(11):1076-83. doi: 10.1016/S1474-4422(13)70227-8. Epub 2013 Oct 1.

PMID:
24090588
15.

Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals.

Schiffelers RM, van der Vaart TK, Storm G.

BioDrugs. 2011 Jun 1;25(3):171-89. doi: 10.2165/11589330-000000000-00000. Review.

PMID:
21627341
16.

Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.

van der Vaart T, van Woerden GM, Elgersma Y, de Zeeuw CI, Schonewille M.

Genes Brain Behav. 2011 Jun;10(4):404-9. doi: 10.1111/j.1601-183X.2011.00685.x. Epub 2011 Mar 22.

Supplemental Content

Loading ...
Support Center